Iovance Biotherapeutics Inc Long-term Investment Intensity
Iovance Biotherapeutics Inc long-term investment intensity. Iovance Biotherapeutics Inc (IOVA) has a Long-term Investment Intensity of 4.0% as of March 2022. Long-term investments of $27.70 Million represent 4.0% of total assets of $701.25 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Iovance Biotherapeutics Inc debt and liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Iovance Biotherapeutics Inc (2021–2021)
Long-term investment intensity of Iovance Biotherapeutics Inc from 2021 to 2021. This chart shows how Iovance Biotherapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of March 2022, the intensity stands at 4.0%, reflecting long-term investments of $27.70 Million against total assets of $701.25 Million USD.
Iovance Biotherapeutics Inc Long-term Investment Intensity by Year (2021–2021)
Iovance Biotherapeutics Inc long-term investment intensity by year from 2021 to 2021. The table below presents the year-by-year Long-term Investment Intensity for Iovance Biotherapeutics Inc from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see IOVA total asset value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 11.8% | $91.59 Million | $777.33 Million | — |